These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30180161)

  • 1. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
    Tworoger SS; Zhang X; Eliassen AH; Qian J; Colditz GA; Willett WC; Rosner BA; Kraft P; Hankinson SE
    J Clin Oncol; 2014 Oct; 32(28):3111-7. PubMed ID: 25135988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.
    Hüsing A; Fortner RT; Kühn T; Overvad K; Tjønneland A; Olsen A; Boutron-Ruault MC; Severi G; Fournier A; Boeing H; Trichopoulou A; Benetou V; Orfanos P; Masala G; Pala V; Tumino R; Fasanelli F; Panico S; Bueno de Mesquita HB; Peeters PH; van Gills CH; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Khaw KT; Travis RC; Dossus L; Li K; Ferrari P; Merritt MA; Tzoulaki I; Riboli E; Kaaks R
    Clin Cancer Res; 2017 Aug; 23(15):4181-4189. PubMed ID: 28246273
    [No Abstract]   [Full Text] [Related]  

  • 4. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
    Eliassen AH; Missmer SA; Tworoger SS; Hankinson SE
    J Clin Oncol; 2006 Apr; 24(12):1823-30. PubMed ID: 16567770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
    Rice MS; Tworoger SS; Hankinson SE; Tamimi RM; Eliassen AH; Willett WC; Colditz G; Rosner B
    Breast Cancer Res Treat; 2017 Nov; 166(1):227-240. PubMed ID: 28702896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JWT; Tice JA; Ziv E; Kerlikowske K; Cummings SR
    Breast Cancer Res Treat; 2017 Nov; 166(2):603-612. PubMed ID: 28791495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
    Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
    J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States).
    Hankinson SE; Colditz GA; Hunter DJ; Manson JE; Willett WC; Stampfer MJ; Longcope C; Speizer FE
    Cancer Causes Control; 1995 May; 6(3):217-24. PubMed ID: 7612801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
    Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
    Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.